 | Up a level |
2022
Feenstra, Helena M. A., Hahn, Leo C., van Rijssen, Thomas J., Tsonaka, Roula, Breukink, Myrte B., Keunen, Jan E. E., Peters, Petrus J. H., Dijkman, Greet, Souied, Eric H., MacLaren, Robert E., Querques, Giuseppe 
ORCID: 0000-0002-3292-9581, Downes, Susan M., Fauser, Sascha, Hoyng, Carel B., van Dijk, Elon H. C. and Boon, Camiel J. F.
(2022).
EFFICACY OF HALF-DOSE PHOTODYNAMIC THERAPY VERSUS HIGH-DENSITY SUBTHRESHOLD MICROPULSE LASER FOR TREATING PIGMENT EPITHELIAL DETACHMENTS IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Retin.-J. Retin. Vitr. Dis., 42 (4).
S. 721 - 730.
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 1539-2864
2021
van Rijssen, Thomas J., van Dijk, Elon H. C., Scholz, Paula, Breukink, Myrte B., Dijkman, Greet, Peters, Petrus J. H., Tsonaka, Roula, Keunen, Jan E. E., MacLaren, Robert E., Hoyng, Carel B., Downes, Susan M., Fauser, Sascha and Boon, Camiel J. F. (2021). Long-term follow-up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser. Acta Ophthalmol., 99 (7). S. 805 - 812. HOBOKEN: WILEY. ISSN 1755-3768
2020
van Rijssen, Thomas J., van Dijk, Elon H. C., Scholz, Paula, Breukink, Myrte B., Dijkman, Greet, Peters, Petrus J. H., Tsonaka, Roula, MacLaren, Robert E., Downes, Susan M., Fauser, Sascha, Boon, Camiel J. F. and Hoyng, Carel B. (2020). Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial. Am. J. Ophthalmol., 216. S. 80 - 90. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-1891
2018
van Dijk, Elon H. C., Fauser, Sascha, Breukink, Myrte B., Blanco-Garavito, Rocio, Groenewoud, Joannes M. M., Keunen, Jan E. E., Peters, Petrus J. H., Dijkman, Greet, Souied, Eric H., MacLaren, Robert E., Querques, Giuseppe ORCID: 0000-0002-3292-9581, Downes, Susan M., Hoyng, Carel B. and Boon, Camiel J. F.
(2018).
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy The PLACE Trial.
Ophthalmology, 125 (10).
S. 1547 - 1556.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1549-4713